Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 848 results for "for merck"

Merck KGaA (ADR) (NYSE:MRK) Had Its TP Downgraded by 6.67 % at Goldman Sachs to $56.00
Octafinance

Conestoga Capital Advisors Sells 500 Shares of Merck & Co., In...

Conestoga Capital Advisors reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 5.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,000 ... Ticker Report, 9 hours ago
[x]  

306 images for for merck

American Banking News, 2 days ago
Watch List News, 2 days ago
TechMoran, 9 hours ago
WTOL-TV, 2 days ago
Yahoo! Singapore, 2 days ago
Business Standard India, 1 day ago
Broadway World, 2 days ago
Review Seeker, 4 days ago
Tekedia, 3 days ago
The Star (Kenya), 4 days ago

MSD brings shingles vaccine to boost India offering

NEW DELHI: US drug maker Merck has introduced Zostavax, its vaccine brand that prevents a painful viral infection. The product that posted worldwide sales of over $750 million (Rs5,133 crore) in 2014 will now be available here at Rs7,500-8,000 ...
 Economic Times18 hours ago

Sun Pharma calls off Merck deal

Sun Pharmaceutical Industries and Merck Sharp & Dohme (MSD) have decided to terminate a joint venture to develop, manufacture and commercialise branded generics for emerging markets. Sun Pharma today said the partners had put in significant efforts to pursue ...
 The Telegraph1 day ago Sun Pharma to end venture with Merck & Co  Business Line1 day ago Merck & Co., Sun Pharmaceutical terminate branded-generics joint venture  FirstWord Pharma1 day ago Sun Pharma Shares Jump After Quarterly Earnings Beat Estimates  Equilibrio Informativo1 day ago
Reuters India

Sun Pharma to wind down JV with Merck

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai May 29, 2014. Reuters/Danish Siddiqui/Files MUMBAI India's largest drugmaker, Sun Pharmaceutical Industries Ltd( ...
 Reuters India1 day ago Sun Pharma Q3 profit beats Street, to wind down JV with Merck  Reuters1 day ago Sun Pharma's Q3 profit beats estimates  Sify1 day ago Sun Pharma to seek FDA re-inspection of Halol plant by end-June  Reuters UK1 day ago
[x]  

Merck to consider dividend

Merck Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 26, 2016, to consider and approve the audited financial results for the year ended December 31, 2015 and to consider recommendation of dividend for the ...
 Money Control1 day ago

4 - Merck Sharp & Dohme Research GmbH (0001665244) (Reporting)

Filing Date 2016-02-10 Accepted 2016-02-10 16:28:20 Documents 1 Period of Report 2016-02-08 Filing Date Changed 2016-02-10 Document Format Files Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 ...
 SEC3 days ago 4 - Merck Sharp & Dohme Corp. (0000942443) (Reporting)  SEC3 days ago Merck & Co., Inc. (0000310158) (Subject)  SEC Filings3 days ago Merck & Co., Inc. (0000310158) (Filed by)  SEC Filings1 day ago
Biz Community

Merck launches second digital health accelerator programme in Africa

Technology and pharma company Merck is open for applications to its second accelerator programme for digital health in Nairobi, Kenya this April. Startups will receive equity-free funding of $15,000 funding, three months coaching and mentoring as ...
 Biz Community3 days ago Merck launches Accelerator Program for Digital Healthcare in Nairobi  Africa-On The Rise2 days ago Merck moves into Kenya with equity-free accelerator digital healthcare  Tekedia4 days ago Merck's digital health accelerator expands into Africa  PC Tech Magazine5 days ago
India Infoline

FDA clears Lannett's generic version of Merck's Temodar

News Editor The FDA approves Lannett Company's (NYSE:LCI) temozolomide capsules, its generic equivalent to Merck's (NYSE:MRK) chemo drug Temodar Capsules. According to IMS, annual U.S. sales of the branded product are
 Seeking Alpha2 days ago Lannett passes US FDA approval for chemotherapy agent Temozolomide  Bloomberg1 day ago Glenmark Pharma tanks 5% on patent infringement lawsuit; FDA nod goes in vain  India Infoline2 months ago

T-Hub to roll out health technology accelerator

T-Hub Health Tech Innovation Accelerator will be set up in partnership with pharmaceutical major Merck and Microsoft Ventures
 Business Standard2 days ago T-Hub to launch accelerator programme in April  The Hindu2 days ago T-Hub to launch its first accelerator for health-tech startups  Economic Times3 days ago

IMMUNOGEN : and Merck Establish Collaboration for Clinical Evaluation of Mirvetuximab Soravtansine in Combination with Keytruda® pembrolizumab for the...

ImmunoGen and Merck Establish Collaboration for Clinical Evaluation of Mirvetuximab Soravtansine in Combination with Keytruda® pembrolizumab for the Treatment of Ovarian Cancer By a News Reporter-Staff News Editor at Clinical Trials Week -- ...
 4 Traders2 days ago ImmunoGen, Merck collaborate on clinical study of mirvetuximab soravtansine in combo with Keytruda to treat ovarian cancer  PharmaBiz1 week ago ImmunoGen to evaluate combo of lead product candidate and Merck's Keytruda in ovarian cancer  Seeking Alpha1 week ago ImmunoGen, Merck & Co. Launch Cancer ...  Genetic Engineering News1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less